Rapid response of treatment-resistant pemphigus foliaceus to the anti-CD20 antibody rituximab
- 1 October 2003
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 149 (4), 899-901
- https://doi.org/10.1046/j.1365-2133.2003.05580.x
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapyArthritis & Rheumatism, 2001
- Treatment of childhood autoimmune haemolytic anaemia with rituximabThe Lancet, 2001
- Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: Report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLLAmerican Journal of Hematology, 2001
- Pemphigus and bullous pemphigoidThe Lancet, 1999
- Usefulness of enzyme-linked immunosorbent assay using recombinant desmogleins 1 and 3 for serodiagnosis of pemphigusBritish Journal of Dermatology, 1999
- Rituxan in the Treatment of Cold Agglutinin DiseaseBlood, 1998
- Antigen-Specific Immunoadsorption of Pathogenic Autoantibodies in Pemphigus FoliaceusJournal of Investigative Dermatology, 1995
- Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigusBritish Journal of Dermatology, 1988